These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33517123)

  • 1. Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-070-02) from a patient with neurodegeneration with brain iron accumulation (NBIA) having compound heterozygous mutations in PANK2 gene.
    Ou-Yang CH; Tai CH; Lin HY; Huang CY; Lin CH
    Stem Cell Res; 2021 Mar; 51():102190. PubMed ID: 33517123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a patient with neurodegeneration with brain iron accumulation (NBIA) harboring a novel frameshift mutation in C19orf12 gene.
    Lin HY; Ou-Yang CH; Lin CH
    Stem Cell Res; 2020 Dec; 49():102032. PubMed ID: 33068888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.
    Kurian MA; Hayflick SJ
    Int Rev Neurobiol; 2013; 110():49-71. PubMed ID: 24209433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation.
    Álvarez-Córdoba M; Fernández Khoury A; Villanueva-Paz M; Gómez-Navarro C; Villalón-García I; Suárez-Rivero JM; Povea-Cabello S; de la Mata M; Cotán D; Talaverón-Rey M; Pérez-Pulido AJ; Salas JJ; Pérez-Villegas EM; Díaz-Quintana A; Armengol JA; Sánchez-Alcázar JA
    Mol Neurobiol; 2019 May; 56(5):3638-3656. PubMed ID: 30173408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms.
    Aggarwal A; Schneider SA; Houlden H; Silverdale M; Paudel R; Paisan-Ruiz C; Desai S; Munshi M; Sanghvi D; Hardy J; Bhatia KP; Bhatt M
    Mov Disord; 2010 Jul; 25(10):1424-31. PubMed ID: 20629144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration with brain iron accumulation.
    Hayflick SJ; Kurian MA; Hogarth P
    Handb Clin Neurol; 2018; 147():293-305. PubMed ID: 29325618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA) but mutations are rare in other types of adult neurodegenerative disease.
    Matarin MM; Singleton AB; Houlden H
    Neurosci Lett; 2006 Oct; 407(2):162-5. PubMed ID: 16962235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
    Thomas M; Hayflick SJ; Jankovic J
    Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration.
    Santambrogio P; Ripamonti M; Paolizzi C; Panteghini C; Carecchio M; Chiapparini L; Raimondi M; Rubio A; Di Meo I; Cozzi A; Taverna S; De Palma G; Tiranti V; Levi S
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives.
    Álvarez-Córdoba M; Talaverón-Rey M; Villalón-García I; Povea-Cabello S; Suárez-Rivero JM; Suárez-Carrillo A; Munuera-Cabeza M; Salas JJ; Sánchez-Alcázar JA
    Orphanet J Rare Dis; 2021 May; 16(1):201. PubMed ID: 33952316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.
    Talaverón-Rey M; Álvarez-Córdoba M; Villalón-García I; Povea-Cabello S; Suárez-Rivero JM; Gómez-Fernández D; Romero-González A; Suárez-Carrillo A; Munuera-Cabeza M; Cilleros-Holgado P; Reche-López D; Piñero-Pérez R; Sánchez-Alcázar JA
    Orphanet J Rare Dis; 2023 Apr; 18(1):80. PubMed ID: 37046296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Imaging Presentation of a Patient with Beta-Propeller Protein-Associated Neurodegeneration, a Rare and Sporadic form of Neurodegeneration with Brain Iron Accumulation (NBIA).
    Hattingen E; Handke N; Cremer K; Hoffjan S; Kukuk GM
    Clin Neuroradiol; 2017 Dec; 27(4):481-483. PubMed ID: 28643035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease.
    Arber C; Angelova PR; Wiethoff S; Tsuchiya Y; Mazzacuva F; Preza E; Bhatia KP; Mills K; Gout I; Abramov AY; Hardy J; Duce JA; Houlden H; Wray S
    PLoS One; 2017; 12(9):e0184104. PubMed ID: 28863176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2.
    Kotzbauer PT; Truax AC; Trojanowski JQ; Lee VM
    J Neurosci; 2005 Jan; 25(3):689-98. PubMed ID: 15659606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
    Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
    AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation.
    Wang ZB; Liu JY; Xu XJ; Mao XY; Zhang W; Zhou HH; Liu ZQ
    Biomed Pharmacother; 2019 Oct; 118():109068. PubMed ID: 31404774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel compound heterozygous PANK2 gene mutations in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration.
    Cheng Y; Liu YT; Yang ZH; Yang J; Shi CH; Xu YM
    Int J Neurosci; 2018 Dec; 128(12):1109-1113. PubMed ID: 29962256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.
    Hayflick SJ
    Curr Opin Pediatr; 2003 Dec; 15(6):572-7. PubMed ID: 14631201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
    Tanteles GA; Spanou-Aristidou E; Antoniou C; Christophidou-Anastasiadou V; Kleopa KA
    J Neurol Sci; 2014 May; 340(1-2):233-6. PubMed ID: 24655737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.
    Álvarez-Córdoba M; Reche-López D; Cilleros-Holgado P; Talaverón-Rey M; Villalón-García I; Povea-Cabello S; Suárez-Rivero JM; Suárez-Carrillo A; Munuera-Cabeza M; Piñero-Pérez R; Sánchez-Alcázar JA
    Orphanet J Rare Dis; 2022 Aug; 17(1):311. PubMed ID: 35945593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.